Costs and outcomes of antimicrobial stewardship for children
A pilot stewardship programme in two primary hospitals in Gondar Zone improved prescribing for hospitalised children, but its costs and value have not been assessed. This project estimates the economic burden of antimicrobial resistance in these hospitals and the cost-effectiveness of the programme.
Challenge
Drug-resistant bloodstream infections account for a large share of hospital deaths among children in Ethiopia. Stewardship programmes are being piloted in primary hospitals, and decision makers need evidence on whether they are worth expanding.
Approach
A cost-of-illness model separates direct costs, such as antimicrobials, blood cultures and bed-days, from indirect costs such as caregiver time and out-of-pocket spending. A Markov cohort model compares the stewardship programme with standard care over a lifetime horizon, with QALYs as the main outcome. The analysis also looks at how costs and benefits fall across households.
Progress
The modelling protocol is complete and is with the ethics committee. Stewardship teams at Metema and Debark primary hospitals have agreed to share clinical, microbiology, pharmacy and audit data once approval is in place. The Ministry of Health and the regional health bureau have been briefed ahead of a model validation workshop.
Expected outputs
Estimates of the cost of resistance among children in hospital, the cost-effectiveness of stewardship in primary hospitals, and evidence for national scale-up.
More in Pharmaceutical & supply chain.
Ongoing
Pharmaceutical & supply chainRepurposing metformin to improve TB treatment outcomes
A randomised proof-of-concept trial testing whether adding metformin to standard tuberculosis therapy protects lung function, in the first such study in sub-Saharan Africa.
30 months Read more
Ongoing
Pharmaceutical & supply chainMalaria rapid diagnostic tests in community pharmacies
Community pharmacies are often the first place people with fever go, but they sit outside Ethiopia’s malaria diagnostic system and antimalarials are often sold without a…
February 2026 – January 2027 Read moreWork with us.
We take enquiries from governments, development partners, research institutions and implementers on research, advisory and training engagements.










